Charles Okyere Boadu: Blood Donation Helps Lower Your Risk of Stroke and Organ Damage
Charles Okyere Boadu, Medical Laboratory Science Student at the University for Development Studies, shared on LinkedIn:
”Donating blood may protect more than patients.
It could help lower the risk of stroke and organ damage in some donors.
We all know that donating blood saves lives for patients battling cancer, undergoing surgery, surviving trauma, or managing chronic illnesses.
But beyond saving others, blood donation can sometimes help save your own life too.
Many people rarely go for routine medical check ups unless they feel sick.
Yet every time you donate blood, you go through a mandatory screening process including a haemoglobin test.
This simple test works like a mini health check and can reveal important clues about your internal health.
For example, some people unknowingly live with Polycythemia Vera, a rare condition where the body produces too many red blood cells.
Most people with this condition has no early symptoms, so it can remain hidden for a long time.
During donor screening, an unusually high haemoglobin level can become an early warning sign.
The laboratory scientist can then prompt the donor to visit the hospital for further checks, monitoring, education, and treatment.
In people diagnosed with Polycythemia Vera, therapeutic venesection is often done to reduce the thickness of the blood and lower the risk of complications.
If this condition is not detected early, the blood can become too thick and lead to life threatening complications such as stroke, heart attack, and other cardiovascular problems.
Imagine walking in to donate blood to save a stranger and discovering a condition that was silently threatening your own future.
The lesson is simple. When you step forward to save a life through blood donation, you may also uncover hidden health conditions that help protect your own life.
Donate blood. Save lives and possibly your own too.”
Stay updated with Hemostasis Today.
-
Sep 5, 2026, 19:20Yubrine Moraa Gachemba: BETULA Adds New Evidence for Catheter-Directed Thrombolysis in PE
-
Sep 5, 2026, 19:18John R. Mehall: The Importance of Anticoagulation Management in ECMO
-
Sep 5, 2026, 19:16Thirunavukkarasu Angappan: Why Hemophilia B Still Needs Both Plasma-Derived and Recombinant Factor IX
-
Sep 5, 2026, 19:15Michelle Leona Cecil: Comprehensive Hemophilia Care Doesn’t Begin and End With One Appointment
-
Sep 5, 2026, 19:13Amparo Santamaria: Stem Cells and Hematology – Unlocking a New Frontier in Ovarian Regeneration
-
Sep 5, 2026, 19:10Strengthening the Public Health System for Blood Disorders – Hemophilia Federation of America
-
Sep 5, 2026, 19:08Deidra D. Harris: Supporting Hemophilia of Georgia and the Bleeding Disorders Community
-
Sep 5, 2026, 19:06Katherine Blackwell: Blessed to Have the Opportunity to Speak at the Hemophilia of Indiana Annual Meeting
-
Sep 5, 2026, 19:04Christy V.: What You Need to Know about GI Bleeding and Hemophilia